Company Analysis

Gain Therapeutics, Inc. (GANX)

Nasdaq: GANX · Pharmaceutical Preparations · Bethesda, MD · filing with the SEC since 2020
Grade4.2
◀ Past 3.7● Present 3.6▶ Future 5.0
2 est.

Filings

160 filings since 2017 beside 82 insider forms · Non-accelerated filer and smaller reporting company and emerging growth company · read from EDGAR on Nov 13, 2026
Due nextNon-accelerated filer and smaller reporting company and emerging growth company
10-K Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Mar 31, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by May 15, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 41 days after the quarter ended. The proxy statement was last filed Apr 28, 2026.

Filings a yearinsider forms included
4463640454130
2020202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 7 times in the last 36 months, the newest Oct 28, 2026.Listing warning from its exchange (8-K item 3.01): 2 times in the last 36 months, the newest Jan 15, 2025.SEC letters: 3 in the last 36 months, the newest Jun 4, 2025.
Insider forms 82

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 10, 2026 10-Q Quarterly report Sep 30, 2026
Nov 10, 2026 8-K items 2.02, 9.01 Results released · Current report
Oct 28, 2026 8-K items 5.02, 9.01 Officer or director change · Current report Oct 22, 2026
Oct 1, 2026 8-K item 8.01 Other event · Current report
Sep 28, 2026 8-K item 5.02 Officer or director change · Current report Sep 22, 2026
Aug 11, 2026 10-Q Quarterly report Jun 30, 2026
Aug 11, 2026 8-K items 2.02, 9.01 Results released · Current report
Jul 16, 2026 8-K item 8.01 Other event · Current report
Jun 29, 2026 8-K item 8.01 Other event · Current report
Jun 25, 2026 8-K item 5.07 Shareholder vote · Current report Jun 24, 2026
May 26, 2026 8-K item 8.01 Other event · Current report
May 11, 2026 10-Q Quarterly report Mar 31, 2026
May 11, 2026 8-K items 2.02, 9.01 Results released · Current report
Apr 28, 2026 ARS Annual report to shareholders Dec 31, 2025
Apr 28, 2026 DEFA14A Extra proxy material
Apr 28, 2026 DEF 14A Proxy statement Jun 24, 2026
Mar 26, 2026 10-K Annual report Dec 31, 2025
Mar 26, 2026 8-K items 2.02, 9.01 Results released · Current report
Mar 18, 2026 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report
Feb 3, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Dec 18, 2025 8-K item 8.01 Other event · Current report
Dec 3, 2025 S-8 Employee stock plan registration
Nov 28, 2025 8-K items 8.01, 9.01 Other event · Current report
Nov 28, 2025 424B5 Shelf offering
Nov 12, 2025 10-Q Quarterly report Sep 30, 2025
Nov 12, 2025 8-K items 2.02, 9.01 Results released · Current report
Nov 7, 2025 S-3/A Shelf registration, amended
Oct 14, 2025 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Oct 9, 2025 8-K item 5.02 Officer or director change · Current report Oct 6, 2025
Oct 6, 2025 8-K item 8.01 Other event · Current report
Aug 12, 2025 10-Q Quarterly report Jun 30, 2025
Aug 12, 2025 8-K items 2.02, 9.01 Results released · Current report
Jul 17, 2025 424B5 Shelf offering
Jul 17, 2025 8-K items 1.01, 3.02, 7.01, 9.01 Major agreement signed; Shares sold without registration; Investor disclosure (Regulation FD) · Current report Jul 15, 2025
Jul 15, 2025 424B5 Shelf offering
Jun 30, 2025 8-K item 8.01 Other event · Current report
Jun 24, 2025 8-K items 5.03, 5.07, 9.01 Charter, bylaw or fiscal-year change; Shareholder vote · Current report
Jun 4, 2025 UPLOAD SEC comment letter
May 28, 2025 S-3 Shelf registration
May 14, 2025 10-Q Quarterly report Mar 31, 2025
40 of 160 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton GANX · research, not advice